Indications:
This lotion contains the active ingredients halobetasol propionate and tazarotene and is used to treat plaque psoriasis in adults.

Dosage and administration:
Route of administration: Topical.
Apply a thin layer of Halotaz lotion once daily to cover only affected areas and rub gently. If a bath or shower is taken prior to application, the skin should be dry before applying the lotion.
The total dosage should not exceed approximately 50 gm per week because of the potential for the drug to suppress hypothalamic-pituitary-adrenal (HPA) axis. Avoid application of Halotaz lotion from oral, ophthalmic or intravaginal use.
Or as directed by physicians.

Interaction:
With Medicine: It is contraindicated with patients who are taking corticosteroids by mouth
or injection, or use other products on skin that contain corticosteroids.
With food and others: No data available with interaction of food.

Contraindications:
This lotion should not be used during pregnancy.

pregnancy and lactation:
Halotaz lotion is contraindicated in women who are pregnant. There are no data on the presence of Tazarotene and Halobetasol Propionate or its metabolites in human milk.

Children and adolescents:
Safety and effectiveness of Halotaz lotion in patients under the age of 18 years have not been evaluated.

Overdose:
No data available on the overdose of Halotaz lotion.

Side Effects:
Redness, itching, swelling, burning, stinging, application site pain, inflamed hair follicles (folliculitis), skin thinning (atrophy), peeling, and rash are the most prevalent side effects.